Trial Profile
Comparative study of efficacy and safety of Administering 4mg once daily and 2mg twice daily of silodosin in patients with benign prostatic hyperplasia.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2009
Price :
$35
*
At a glance
- Drugs Silodosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 10 Aug 2009 New trial record